R406 is an inhibitor of the spleen tyrosine kinase (SYK) that only induces apoptosis in DLBCL cell lines having an active BCR signaling, whereas non-BCR DLBCL cell lines that do not display functional BCR signaling are insensitive to this inhibitor. The gene discussed is BCR; the disease is diffuse large B-cell lymphoma.